.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Dow
UBS
Chubb
Express Scripts
Fuji
Queensland Health
Covington
Accenture
Cerilliant

Generated: June 26, 2017

DrugPatentWatch Database Preview

Dicumarol - Generic Drug Details

« Back to Dashboard

What are the generic sources for dicumarol and what is the scope of dicumarol patent protection?

Dicumarol
is the generic ingredient in one branded drug marketed by Lilly and Abbvie, and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for dicumarol.

Summary for Generic Name: dicumarol

Tradenames:1
Patents:1
Applicants:2
NDAs:2
Drug Master File Entries: see list1
Bulk Api Vendors: see list46
Clinical Trials: see list1
Patent Applications: see list4,231
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dicumarol at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
DICUMAROL
dicumarol
TABLET;ORAL005545-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
DICUMAROL
dicumarol
CAPSULE;ORAL005509-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Abbvie
DICUMAROL
dicumarol
TABLET;ORAL005545-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
DICUMAROL
dicumarol
CAPSULE;ORAL005509-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Abbvie
DICUMAROL
dicumarol
TABLET;ORAL005545-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Express Scripts
Argus Health
Johnson and Johnson
Merck
Boehringer Ingelheim
Farmers Insurance
Moodys
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot